HealthEdge Announces Successful Sale of LifeSync to Amphenol

Core Insights - HealthEdge Investment Partners has successfully sold LifeSync, a company specializing in patient monitoring devices, to Amphenol, a leading provider of connectors and interconnect systems [1][2] - LifeSync experienced significant growth, increasing its revenues from $5 million to approximately$100 million during HealthEdge's investment period [2] Group 1: HealthEdge Investment Partners - HealthEdge is a private equity firm focused exclusively on the healthcare industry, founded in 2005 [3] - The firm aims to achieve superior returns by leveraging the knowledge and experience of its partners, who have over 100 years of combined experience in healthcare [3] Group 2: LifeSync - LifeSync is a vertically integrated company that specializes in patient connections, including cardiac cables, leadwires, and neuromonitoring connections [4] - The company has a state-of-the-art manufacturing facility located in Coral Springs, Florida [4] Group 3: Amphenol - Amphenol Corporation is one of the largest manufacturers of electrical, electronic, and fiber optic connectors, with a presence in approximately 40 countries [5] - The company operates in high-growth areas such as Automotive, Commercial Aerospace, and Defense, among others [5]